HomeVRAX • NASDAQ
add
Virax Biolabs Group Ltd
Previous close
$0.35
Day range
$0.35 - $0.37
Year range
$0.35 - $3.20
Market cap
2.42M USD
Avg Volume
10.32M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 804.00 | -67.53% |
Operating expense | 1.29M | -9.94% |
Net income | -1.17M | 15.15% |
Net profit margin | -145.45K | -161.30% |
Earnings per share | — | — |
EBITDA | -1.21M | 12.66% |
Effective tax rate | 10.46% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.44M | -53.43% |
Total assets | 5.72M | -39.48% |
Total liabilities | 641.52K | -37.48% |
Total equity | 5.07M | — |
Shares outstanding | 6.54M | — |
Price to book | 0.43 | — |
Return on assets | -56.55% | — |
Return on capital | -57.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.17M | 15.15% |
Cash from operations | -1.38M | -43.87% |
Cash from investing | -70.75K | 42.94% |
Cash from financing | 1.01M | -65.58% |
Net change in cash | -441.74K | -123.90% |
Free cash flow | -754.30K | 19.16% |
About
Founded
2013
Website
Employees
19
